Major efforts to sequence cancer genomes are now occurring throughout the world. Though the emerging data from these studies are illuminating, their reconciliation with epidemiologic and clinical observations poses a major challenge. In the current study, we provide amathematical model that begins to address this challenge. We model tumors as a discrete time branching process that starts with a single driver mutation and proceeds as each new driver mutation leads to a slightly increased rate of clonal expansion. Using the model, we observe tremendous variation in the rate of tumor development—providing an understanding of the heterogeneity in tumor sizes and development times that have been observed by epidemiologists and clinicians. Furthe...
Cancer is an evolutionary process involving the accumulation of somatic mutations in the genome. The...
Tumorigenesis in humans is thought to be a multistep process where certain mutations confer a select...
Cancer drivers are genomic alterations that provide cells containing them with a selective advantage...
Major efforts to sequence cancer genomes are now occurring throughout the world. Though the emerging...
<div><p>The vast majority of mutations in the exome of cancer cells are passengers, which do not aff...
Cancer progression is determined by the accumulation of a number of key mutations. These can be coar...
Tumor growth is caused by the acquisition of driver mutations, which enhance the net reproductive ra...
Cancer progression is driven by the accumulation of a small number of genetic alterations. However, ...
Cancer develops through a process of somatic evolution1,2. Sequencing data from a single biopsy repr...
Abstract Background A unified analysis of DNA sequences from hundreds of tumors concluded that the d...
Human cancer somatic mutations arise from a variety of biological processes. Different processes pro...
genome-wide measurements of somatic mutations in large numbers of cancer patients. A major challenge...
Background Tumors are widely recognized to progress through clonal evolution by sequentially acquir...
We investigate the dynamics of cancer initiation in a mathematical model with one driver mutation an...
© 2020 Luis Eduardo Lara-GonzalezIntra and inter-tumour heterogeneity poses a challenge for associat...
Cancer is an evolutionary process involving the accumulation of somatic mutations in the genome. The...
Tumorigenesis in humans is thought to be a multistep process where certain mutations confer a select...
Cancer drivers are genomic alterations that provide cells containing them with a selective advantage...
Major efforts to sequence cancer genomes are now occurring throughout the world. Though the emerging...
<div><p>The vast majority of mutations in the exome of cancer cells are passengers, which do not aff...
Cancer progression is determined by the accumulation of a number of key mutations. These can be coar...
Tumor growth is caused by the acquisition of driver mutations, which enhance the net reproductive ra...
Cancer progression is driven by the accumulation of a small number of genetic alterations. However, ...
Cancer develops through a process of somatic evolution1,2. Sequencing data from a single biopsy repr...
Abstract Background A unified analysis of DNA sequences from hundreds of tumors concluded that the d...
Human cancer somatic mutations arise from a variety of biological processes. Different processes pro...
genome-wide measurements of somatic mutations in large numbers of cancer patients. A major challenge...
Background Tumors are widely recognized to progress through clonal evolution by sequentially acquir...
We investigate the dynamics of cancer initiation in a mathematical model with one driver mutation an...
© 2020 Luis Eduardo Lara-GonzalezIntra and inter-tumour heterogeneity poses a challenge for associat...
Cancer is an evolutionary process involving the accumulation of somatic mutations in the genome. The...
Tumorigenesis in humans is thought to be a multistep process where certain mutations confer a select...
Cancer drivers are genomic alterations that provide cells containing them with a selective advantage...